These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285 [Abstract] [Full Text] [Related]
3. Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. Rogachefsky RA, Dean DD, Howell DS, Altman RD. Osteoarthritis Cartilage; 1993 Apr; 1(2):105-14. PubMed ID: 8886086 [Abstract] [Full Text] [Related]
4. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage. Ratcliffe A, Azzo W, Saed-Nejad F, Lane N, Rosenwasser MP, Mow VC. J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029 [Abstract] [Full Text] [Related]
5. Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Clemmons DR, Busby WH, Garmong A, Schultz DR, Howell DS, Altman RD, Karr R. Arthritis Rheum; 2002 Mar; 46(3):694-703. PubMed ID: 11920405 [Abstract] [Full Text] [Related]
7. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, Cole AA. Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187 [Abstract] [Full Text] [Related]
8. Effects of moving training on histology and biomarkers levels of articular cartilage. Qi C, Changlin H. J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690 [Abstract] [Full Text] [Related]
9. Centrifugal and biochemical comparison of proteoglycan aggregates from articular cartilage in experimental joint disuse and joint instability. Müller FJ, Setton LA, Manicourt DH, Mow VC, Howell DS, Pita JC. J Orthop Res; 1994 Jul; 12(4):498-508. PubMed ID: 8064480 [Abstract] [Full Text] [Related]
10. Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage. Dean DD, Azzo W, Martel-Pelletier J, Pelletier JP, Woessner JF. J Rheumatol; 1987 May; 14 Spec No():43-4. PubMed ID: 3305939 [Abstract] [Full Text] [Related]
11. Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. Yamada H, Kikuchi T, Nemoto O, Obata K, Sato H, Seiki M, Shinmei M. J Rheumatol; 1996 Oct; 23(10):1739-43. PubMed ID: 8895151 [Abstract] [Full Text] [Related]
12. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. DiBattista JA, Pelletier JP, Zafarullah M, Fujimoto N, Obata K, Martel-Pelletier J. J Rheumatol Suppl; 1995 Feb; 43():123-8. PubMed ID: 7752115 [Abstract] [Full Text] [Related]
13. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Milner JM, Rowan AD, Cawston TE, Young DA. Arthritis Res Ther; 2006 Feb; 8(5):R142. PubMed ID: 16919164 [Abstract] [Full Text] [Related]
14. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes. Shingleton WD, Jones D, Xu X, Cawston TE, Rowan AD. Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367 [Abstract] [Full Text] [Related]
15. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. Nemoto O, Yamada H, Kikuchi T, Shinmei M, Obata K, Sato H, Seiki M. J Rheumatol; 1997 Sep; 24(9):1774-9. PubMed ID: 9292803 [Abstract] [Full Text] [Related]
16. Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo. Hembry RM, Bagga MR, Dingle JT, Thomas PP, Reynolds JJ. Virchows Arch; 1994 Sep; 425(4):413-24. PubMed ID: 7529620 [Abstract] [Full Text] [Related]
17. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis. Myers SL, Brandt KD, Burr DB, O'Connor BL, Albrecht M. J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377 [Abstract] [Full Text] [Related]
18. Matrix metalloproteinases in the formation of human synovial joint cavities. Edwards JC, Wilkinson LS, Soothill P, Hembry RM, Murphy G, Reynolds JJ. J Anat; 1996 Apr; 188 ( Pt 2)(Pt 2):355-60. PubMed ID: 8621334 [Abstract] [Full Text] [Related]
19. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. Yamada H, Watanabe K, Saito T, Hayashi H, Niitani Y, Kikuchi T, Ito A, Fujikawa K, Lohmander LS. J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178 [Abstract] [Full Text] [Related]
20. Biochemical and biomechanical properties of lesion and adjacent articular cartilage after chondral defect repair in an equine model. Strauss EJ, Goodrich LR, Chen CT, Hidaka C, Nixon AJ. Am J Sports Med; 2005 Nov; 33(11):1647-53. PubMed ID: 16093540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]